Search
Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
News release, 18 February 2022